| Product Code: ETC6661981 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Neuroimaging Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Neuroimaging Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Neuroimaging Market - Industry Life Cycle |
3.4 Canada Neuroimaging Market - Porter's Five Forces |
3.5 Canada Neuroimaging Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Canada Neuroimaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Canada Neuroimaging Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Canada Neuroimaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Canada |
4.2.2 Technological advancements in neuroimaging techniques |
4.2.3 Growing demand for early and accurate diagnosis of brain-related conditions |
4.3 Market Restraints |
4.3.1 High cost associated with neuroimaging procedures |
4.3.2 Limited reimbursement policies for neuroimaging services |
4.3.3 Shortage of skilled professionals in the neuroimaging field |
5 Canada Neuroimaging Market Trends |
6 Canada Neuroimaging Market, By Types |
6.1 Canada Neuroimaging Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Canada Neuroimaging Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Canada Neuroimaging Market Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2021- 2031F |
6.1.4 Canada Neuroimaging Market Revenues & Volume, By Computed Tomography (CT), 2021- 2031F |
6.1.5 Canada Neuroimaging Market Revenues & Volume, By Positron Emission Tomography (PET), 2021- 2031F |
6.1.6 Canada Neuroimaging Market Revenues & Volume, By Single Photon Emission Computed Tomography (SPECT), 2021- 2031F |
6.1.7 Canada Neuroimaging Market Revenues & Volume, By Functional Magnetic Resonance Imaging (fMRI), 2021- 2031F |
6.1.8 Canada Neuroimaging Market Revenues & Volume, By Diffusion Tensor Imaging (DTI), 2021- 2031F |
6.1.9 Canada Neuroimaging Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Canada Neuroimaging Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Canada Neuroimaging Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Canada Neuroimaging Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.3 Canada Neuroimaging Market Revenues & Volume, By Psychiatric Disorders, 2021- 2031F |
6.2.4 Canada Neuroimaging Market Revenues & Volume, By Traumatic Brain Injury (TBI), 2021- 2031F |
6.3 Canada Neuroimaging Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Canada Neuroimaging Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.3 Canada Neuroimaging Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.3.4 Canada Neuroimaging Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.3.5 Canada Neuroimaging Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.6 Canada Neuroimaging Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Neuroimaging Market Import-Export Trade Statistics |
7.1 Canada Neuroimaging Market Export to Major Countries |
7.2 Canada Neuroimaging Market Imports from Major Countries |
8 Canada Neuroimaging Market Key Performance Indicators |
8.1 Average waiting time for neuroimaging procedures |
8.2 Adoption rate of advanced neuroimaging technologies |
8.3 Number of research studies or clinical trials utilizing neuroimaging techniques |
9 Canada Neuroimaging Market - Opportunity Assessment |
9.1 Canada Neuroimaging Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Canada Neuroimaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Canada Neuroimaging Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Canada Neuroimaging Market - Competitive Landscape |
10.1 Canada Neuroimaging Market Revenue Share, By Companies, 2024 |
10.2 Canada Neuroimaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here